Table 2.

Univariate and multivariate Cox analysis for PFS in the training and validation cohorts for patients with advanced HGSOC.

Variable	Univariate Cox regression		Multivariate Cox regression
	HR (95% CI)	P	HR (95% CI)	P
CA125	1.00 (1.00,1.00)	0.08
Age	1.01 (0.99,1.03)	0.27
NACT	1.44 (1.03,2.02)	0.04	1.85 (1.25,2.73)	<0.01
Residual tumor	1.96 (1.38,2.79)	<0.01	1.98 (1.34,2.92)	<0.01
Ascites
<200ml	Reference	Reference
200ml-1000ml	1.47 (0.95,2.28)	0.09	1.56 (0.99,2.45)	0.05
>=1000	1.89 (1.29,2.75)	<0.01	1.63 (1.10,2.42)	0.02
LNM	1.48 (1.08,2.04)	0.02	1.2 (0.86,1.69)	0.28
Location	1.92 (1.33,2.79)	<0.01	1.76 (1.20,2.59)	<0.01
Diameter	1.00 (0.99,1.00)	0.28
FIGO Stage	1.43 (1.02,2.01)	0.00	0.9 (0.82,1.71)	0.37
SUVmedian	0.91 (0.83,1.00)	0.06
TLG	1.00 (1.00,1.00)	0.38
MTV	1.00 (1.00,1.00)	0.12
SUVpeak	0.98 (0.95,1.01)	0.27
SUVmax	0.99 (0.96,1.01)	0.35
SUVmean	0.92 (0.84,1.01)	0.07